4.3 Article

Shedding light on PRAME expression in dysplastic nevi: a cohort study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Dysplastic nevus part I: Historical perspective, classification, and epidemiology

Roman Drozdowski et al.

Summary: The diagnosis and management of dysplastic nevi have long been controversial in dermatology and dermatopathology fields, with diagnostic uncertainty and lack of standardized nomenclature causing confusion. In this CME review article, the historical context and key features for diagnosis, classification, and management of dysplastic nevi are summarized. The article also discusses the diagnostic utility of clinical criteria, dermoscopic features, histopathologic features, total body photography, and reflectance confocal microscopy. (J Am Acad Dermatol 2023;88:1-10.)

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

Article Dermatology

Clinicopathologic and genetic characterization of invasive melanoma with BRAF V600K mutation: A study of 16 cases

Keisuke Goto et al.

Summary: This study found that melanoma with the BRAF V600K mutation mainly occurs on the scalp in elderly men. Histopathologically, it shows non-nested lentiginous intraepidermal growth and subtle solar elastosis, possibly accompanied by intradermal nevus. Immunohistochemistry analysis revealed frequent loss of p16 expression and limited immunoreactivity for PRAME. The tumor mutation burden was intermediate.

JOURNAL OF CUTANEOUS PATHOLOGY (2023)

Article Oncology

PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma

Viola Hedrich et al.

Summary: This study identified PRAME as a target gene of the Gas6/Axl signaling pathway in hepatocellular carcinoma. PRAME promotes dedifferentiation, epithelial-to-mesenchymal transition, and invasion in liver cancer cells. The expression of PRAME is associated with an unfavorable prognosis in HCC patients.

CANCERS (2023)

Article Pathology

Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors

Adam Safanda et al.

Summary: PRAME expression varies in tubo-ovarian epithelial tumors, but is not prognostically significant.

VIRCHOWS ARCHIV (2023)

Article Biochemistry & Molecular Biology

Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas

Elias A. T. Koch et al.

Summary: PRAME is a cancer testis antigen that is highly expressed in melanoma. However, the interpretation of PRAME immunostaining is not standardized, making it difficult to interpret. In this study, PRAME-stained histological slides of superficial spreading melanomas (SSM) and dysplastic nevi (DN) were analyzed using a digital pathology platform. A cut-off score of 97.67 cells/mm(2) was defined to distinguish between DN and SSM. The computer-aided assessment of PRAME immunostaining is a useful tool in dermatopathology to differentiate between DN and SSM.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pathology

Preferentially expressed Antigen in MElanoma immunohistochemistry as an adjunct for evaluating ambiguous melanocytic proliferation

Antonin Fattori et al.

Summary: The histopathological assessment of diagnostically ambiguous melanocytic proliferation remains challenging, but the use of PRAME immunostaining shows promise in distinguishing malignant and benign cases. However, caution should be exercised in interpreting PRAME immunoreactivity, as rare benign melanocytic neoplasms could show positive staining.

HUMAN PATHOLOGY (2022)

Article Dermatology

Analysis of interobserver reproducibility in grading dysplastic nevi: Results of the application of the 2018 World Health Organization grading criteria

Ovgu Aydin Ulgen et al.

Summary: According to 2018 WHO criteria, three pathologists showed good agreement in grading 179 cases of dysplastic nevi, with moderate to good agreement on most architectural features but poor agreement on cytological criteria.

JOURNAL OF CUTANEOUS PATHOLOGY (2022)

Article Dermatology

Genome-Scale DNA Methylation Analysis Identifies Repeat Element Alterations that Modulate the Genomic Stability of Melanocytic Nevi

Mitchell S. Stark et al.

Summary: This study compared the differences between benign and dysplastic melanocytic nevi using genome-wide methylation profiling and identified key epigenetic regulatory mechanisms involved in nevogenesis. It found that benign nevi showed increased genome-scale methylation and methylation of Alu/LINE-1 retrotransposable elements, indicating genomic stability, while dysplastic nevi showed evidence of genomic instability through hypomethylation of Alu/LINE-1. Using dermoscopic classifications, differentially methylated loci were found in reticular/nonspecific patterned nevi but not in globular nevi.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Oncology

Shared Gene Expression and Immune Pathway Changes Associated with Progression from Nevi to Melanoma

Elizabeth S. Borden et al.

Summary: This study aims to develop a gene signature biomarker of melanoma progression and demonstrate its utility in melanoma chemoprevention trials. The researchers identified a small number of genes that can distinguish nevi from melanoma and found shared genes and immune-related pathways associated with progression from nevi to melanoma. The findings highlight the importance of identifying molecular biomarkers and developing chemoprevention strategies to reduce melanoma incidence.

CANCERS (2022)

Review Biochemistry & Molecular Biology

Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis

Costantino Ricci et al.

Summary: This review aims to discuss and summarize all the data related to immunohistochemical analyses that are potentially useful for the accurate diagnosis of cutaneous melanoma, which can have a significant impact on treatment choices.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, General & Internal

PRAME Immunoexpression in 275 Cutaneous Melanocytic Lesions: A Double Institutional Experience

Gerardo Cazzato et al.

Summary: PRAME is a reliable marker in the histopathological diagnosis of melanoma, but should not replace morphological information and ancillary immunohistochemical stains.

DIAGNOSTICS (2022)

Article Cell Biology

PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna

Sarah E. Gradecki et al.

Summary: PRAME IHC is a sensitive (93.5%) and specific (94.7%) method for diagnosing LM on biopsy and excision, and measurement of histological margins by PRAME shows a high correlation with conventional methods for margin assessment. The nuclear expression of PRAME makes it a good target for use in dual-color IHC stains.

HISTOPATHOLOGY (2021)

Article Dermatology

The utility of PRAME staining in identifying malignant transformation of melanocytic nevi

Mary E. Lohman et al.

Summary: PRAME immunohistochemical staining shows a high rate (67%) of differential staining in benign and malignant melanocyte populations in nevus-associated melanoma. In PRAME positive (4+) melanomas, it can differentiate 100% of benign and malignant melanocyte populations, indicating a sensitivity of 67% and a specificity of 100%.

JOURNAL OF CUTANEOUS PATHOLOGY (2021)

Article Dermatology

The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors

Ahmed K. Alomari et al.

Summary: PRAME immunohistochemistry shows high specificity in unequivocal melanomas, with potential utility in distinguishing benign from malignant neoplasms. PRAME positivity is more common in neoplasms favored to be malignant, suggesting a potential role in early diagnosis of melanoma. Additional studies are needed to determine optimal utilization and the potential of hotspot staining to increase sensitivity.

JOURNAL OF CUTANEOUS PATHOLOGY (2021)

Review Reproductive Biology

The PRAME family of cancer testis antigens is essential for germline development and gametogenesis

Chandlar H. Kern et al.

Summary: The PRAME gene family, predominantly expressed in the testis and various tumors, plays multifaceted roles in germ cells as leucine rich repeat proteins localized in the nucleus and cytoplasm. These proteins act as transcriptional regulators in germline development, contributing to the maintenance of embryonic stem cell pluripotency, primordial germ cell development, and spermatogenic/oogenic cell differentiation/proliferation. They are also involved in organelles such as the rough endoplasmic reticulum, Golgi vesicle, germinal granules, centrioles, contributing to spermiogenesis. The PRAME gene family is essential for gametogenesis throughout the entire life cycle, with specific members in male or female germ cells, as well as shared molecular mechanisms with oncogenesis.

BIOLOGY OF REPRODUCTION (2021)

Article Oncology

Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas

Maximilian Gassenmaier et al.

Summary: Histological diagnoses between moderately dysplastic nevi and thin melanomas are not accurate or reproducible, highlighting the need for more objective immunohistochemical markers. PRAME expression can help differentiate melanomas from nevi, but does not provide prognostic information in thin melanomas. The study found that PRAME staining is specific for melanomas, but does not differentiate between metastasizing and non-metastasizing melanomas.

CANCERS (2021)

Article Pathology

Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma

Cecilia Lezcano et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

Article Dermatology

PRAMEexpression in melanocytic proliferations with intermediate histopathologic or spitzoid features

Shyam S. Raghavan et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2020)

Article Oncology

A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer

Zhixian Liu et al.

TRANSLATIONAL ONCOLOGY (2018)

Article Pathology

PRAME Expression in Melanocytic Tumors

Cecilia Lezcano et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)

Editorial Material Oncology

PRAME as diagnostic marker and as regulator for cell fate decisions in germ cell cancers

Nina Neuhaus

BRITISH JOURNAL OF CANCER (2016)

Article Dermatology

Analysis of interobserver reproducibility in grading histological patterns of dysplastic nevi

Aretha Brito Nobre et al.

ANAIS BRASILEIROS DE DERMATOLOGIA (2013)

Review Cell Biology

Dysplastic naevi: an update

David E. Elder

HISTOPATHOLOGY (2010)

Review Biochemistry & Molecular Biology

Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia

Frances Wadelin et al.

MOLECULAR CANCER (2010)

Article Dermatology

Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma

A. R. Shors et al.

BRITISH JOURNAL OF DERMATOLOGY (2006)